ENGERIX-B
Hepatitis B surface antigen (recombinant)
10 mcg / 0.5 mL · suspension · intramuscular · birth to 19 years
Hepatitis B
ENGERIX-B · RECOMBIVAX HB
Three doses over six months; two for some adolescents. Every product below is a Health Canada authorized vaccine; every schedule comes from the Canadian Immunization Guide.
Brand names and DINs (Drug Identification Numbers) as Health Canada's Drug Product Database lists them. The product monograph is the manufacturer's full prescribing information approved by Health Canada.
Hepatitis B surface antigen (recombinant)
10 mcg / 0.5 mL · suspension · intramuscular · birth to 19 years
Hepatitis B surface antigen (recombinant)
20 mcg / 1 mL · suspension · intramuscular · 20 years and older; 11 to 15 two-dose; dialysis as a double dose
Hepatitis B surface antigen (recombinant)
5 mcg / 0.5 mL · solution · intramuscular · birth to 19 years
Hepatitis B surface antigen (recombinant)
10 mcg / 1 mL · suspension · intramuscular · 20 years and older; 11 to 15 two-dose
Hepatitis B surface antigen (recombinant)
10 mcg / 1 mL · solution · intramuscular · 20 years and older; 11 to 15 two-dose
Hepatitis B surface antigen (recombinant), dialysis formulation
40 mcg / 1 mL · suspension · intramuscular · dialysis and some immunocompromised adults 20 and older
Based on the Canadian Immunization Guide's administration practices and acute reactions guidance.
Recommended for people without immunity who are at high risk of exposure.
Use if indicated.
Source: Immunization in pregnancy and breastfeeding: Canadian Immunization Guide — Chapter updated August 2026. Live vaccines are generally contraindicated in pregnancy; routinely recommended vaccines can be given while breastfeeding unless the chapter says otherwise.
The schedules the Canadian Immunization Guide describes for this vaccine. Which one applies depends on age, health and product — use the dose planner to see the dates for your situation.
Standard hepatitis B series at months 0, 1 and 6.
Minimum intervals: 4 weeks between doses 1 and 2, 2 months between doses 2 and 3, and 4 months between doses 1 and 3. The age-appropriate product and dose are chosen by your healthcare professional; blood testing after the series is needed for some people.
Two adult-strength doses at months 0 and 4 to 6, for adolescents 11 to less than 16 years.
For 11 to less than 16 years of age, the standard adult dose (RECOMBIVAX HB 10 mcg, or ENGERIX-B 20 mcg) may be given as two doses, the second 4 to 6 months after the first, when a three-dose series is unlikely to be completed.
Two 20 mcg injections at each of months 0, 1, 2 and 6.
For adults 20 years and older on dialysis, with chronic renal failure or with some immunocompromising conditions, using ENGERIX-B at double the usual dose (40 mcg) at months 0, 1, 2 and 6. Blood testing after the series is required.
The 40 mcg dialysis formulation at months 0, 1 and 6.
For adults 20 years and older on dialysis, with chronic renal failure or with some immunocompromising conditions: RECOMBIVAX HB dialysis formulation (40 mcg) at months 0, 1 and 6. Blood testing after the series is required.
Clinical rules reviewed on 2026-09-27. General information from public Canadian guidance; a personal assessment is needed for treatment decisions. Care365 does not decide whether a vaccine is publicly funded in Ontario.